TR199700782T1 - Interstisyel sistisin tedavisi i�in hiyaluronik asidin kullan�m�. - Google Patents

Interstisyel sistisin tedavisi i�in hiyaluronik asidin kullan�m�.

Info

Publication number
TR199700782T1
TR199700782T1 TR97/00782T TR9700782T TR199700782T1 TR 199700782 T1 TR199700782 T1 TR 199700782T1 TR 97/00782 T TR97/00782 T TR 97/00782T TR 9700782 T TR9700782 T TR 9700782T TR 199700782 T1 TR199700782 T1 TR 199700782T1
Authority
TR
Turkey
Prior art keywords
treatment
hyaluronic acid
cysticin
interstitial
intermittent
Prior art date
Application number
TR97/00782T
Other languages
English (en)
Turkish (tr)
Inventor
Morales Alvaro
Alkemade Stanley
Original Assignee
Bioniche Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/388,038 external-priority patent/US5591724A/en
Application filed by Bioniche Inc. filed Critical Bioniche Inc.
Publication of TR199700782T1 publication Critical patent/TR199700782T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
TR97/00782T 1995-02-14 1996-02-14 Interstisyel sistisin tedavisi i�in hiyaluronik asidin kullan�m�. TR199700782T1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/388,038 US5591724A (en) 1995-02-14 1995-02-14 Method for treating the urinary bladder and associated structures using hyaluronic acid
US59101596A 1996-02-08 1996-02-08

Publications (1)

Publication Number Publication Date
TR199700782T1 true TR199700782T1 (xx) 1998-03-21

Family

ID=27012116

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/00782T TR199700782T1 (xx) 1995-02-14 1996-02-14 Interstisyel sistisin tedavisi i�in hiyaluronik asidin kullan�m�.

Country Status (20)

Country Link
US (1) US5888986A (enExample)
EP (1) EP0813417B1 (enExample)
JP (1) JP4354528B2 (enExample)
KR (1) KR100268660B1 (enExample)
CN (1) CN1181016A (enExample)
AT (1) ATE247476T1 (enExample)
AU (1) AU705289B2 (enExample)
BR (1) BR9607601A (enExample)
CA (1) CA2203621C (enExample)
CZ (1) CZ288218B6 (enExample)
DE (1) DE69629553T2 (enExample)
DK (1) DK0813417T3 (enExample)
ES (1) ES2205013T3 (enExample)
HU (1) HUP9800467A3 (enExample)
IN (1) IN181358B (enExample)
NO (1) NO315842B1 (enExample)
NZ (1) NZ300903A (enExample)
PT (1) PT813417E (enExample)
TR (1) TR199700782T1 (enExample)
WO (1) WO1996025168A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0952855B1 (en) 1991-07-03 2005-07-27 Meditech Research Limited Use of hyaluronan in gene therapy
EP0891775A4 (en) * 1996-12-27 2002-07-24 Seikagaku Kogyo Co Ltd MEDICINE FOR URBAN BLADDER DISORDERS
US6548487B2 (en) 1996-12-27 2003-04-15 Seikagaku Corporation Agent for treatment of bladder troubles
ES2219070T3 (es) * 1998-10-22 2004-11-16 Bioniche Life Sciences Inc. Uso de acido haluronico en el tratamiento de la cistitis por radiacion.
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
DE60036019T2 (de) * 1999-12-13 2008-05-29 Bioniche Life Sciences Inc., Belleville Synthetische oligonukleotide die therapeutisch nützlich sind
US7125858B2 (en) * 1999-12-28 2006-10-24 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
RU2270678C1 (ru) * 2004-06-30 2006-02-27 Государственное образовательное учреждение высшего профессионального образования Российский государственный медицинский университет Министерства здравоохранения Российской Федерации Способ лечения хронического цистита у детей
KR20070121644A (ko) * 2005-01-14 2007-12-27 유리젠, 인코포레이티드 하부 요로 치료용 키트 및 개선된 조성물
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
ES2665254T3 (es) * 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
ITMI20111732A1 (it) * 2011-09-27 2013-03-28 Bsdpharma Srl Formulazioni farmaceutiche per la riduzione della sensibilizzazione crociata tra colon-retto ed il distretto urogenitale con mezzi non-farmacologici.
RU2519010C1 (ru) * 2013-03-20 2014-06-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Композиция для лечения цистита
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
CN103655601B (zh) * 2013-12-31 2019-10-25 上海建华精细生物制品有限公司 一种用于膀胱灌洗的组合物
CN103861091B (zh) * 2014-03-20 2016-04-27 辽宁亿灵科创生物医药科技有限公司 治疗膀胱炎的药物组合物
WO2015154007A1 (en) * 2014-04-03 2015-10-08 Lipella Pharmaceuticals, Inc. Systems and methods of detecting interstitial cystitis
US20160045623A1 (en) 2015-04-03 2016-02-18 Lipella Pharmaceuticals, Inc. Systems and Methods to Image Intercellular and Intercompartmental Defects with Magnetic Resonance Imaging (MRI)
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
GB201616838D0 (en) * 2016-10-04 2016-11-16 Nat Univ Ireland Hyaluronan compositions, and uses thereof in treatment of interstitial cystitis
ES2775673T3 (es) * 2017-05-12 2020-07-27 Farco Gmbh Composición para el tratamiento de enfermedades inflamatorias del tracto urogenital que contiene sulfato de condonita (4,5 mg/ml), ácido hialurónico (16 mg/ml) y tampón de fosfato (pH 6,1 a 7,9) con mayor estabilidad de almacenamiento para tratar la cistitis
IT201900019762A1 (it) * 2019-10-24 2021-04-24 Fidia Farm Spa Composizione farmaceutica per uso nel trattamento della cistite di varia eziologia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4296104A (en) * 1979-08-30 1981-10-20 Herschler R J Therapeutic dimethyl sulfoxide composition and methods of use
US4302577A (en) * 1979-10-05 1981-11-24 Biomed Research Inc. Process for preparing CSA or CSC
US5180715A (en) * 1980-11-17 1993-01-19 The Regents Of The University Of California Irrigation of internal bladder surfaces in mammals with sodium pentosanpolysulfate
DE3118588C2 (de) * 1981-05-11 1983-07-07 Luitpold-Werk, Chemisch-Pharmazeutische Fabrik, 8000 München Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung
US4640912A (en) * 1983-06-09 1987-02-03 Hausman Marvin S Administration of "active" chondroitin sulfate A and "active" chondroitin sulfate C or mixtures thereof to mammals including humans
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
EP0572932B1 (en) * 1992-06-02 2000-09-13 C.R. Bard, Inc. Method and implant device for long term delivery of drugs
JP2995090B2 (ja) * 1993-03-19 1999-12-27 キユー・メド・アクチエボラーグ 組織増大のための組成物および方法

Also Published As

Publication number Publication date
CA2203621A1 (en) 1996-08-22
KR19980702251A (ko) 1998-07-15
CZ257497A3 (cs) 1998-01-14
AU705289B2 (en) 1999-05-20
NO973732L (no) 1997-10-10
DE69629553T2 (de) 2004-06-17
NZ300903A (en) 1999-07-29
HUP9800467A2 (hu) 1998-06-29
JP4354528B2 (ja) 2009-10-28
US5888986A (en) 1999-03-30
CZ288218B6 (en) 2001-05-16
NO973732D0 (no) 1997-08-13
IN181358B (enExample) 1998-05-30
MX9706182A (es) 1998-07-31
ES2205013T3 (es) 2004-05-01
BR9607601A (pt) 1999-09-14
PT813417E (pt) 2003-12-31
WO1996025168A1 (en) 1996-08-22
CA2203621C (en) 1998-04-28
KR100268660B1 (ko) 2000-10-16
ATE247476T1 (de) 2003-09-15
HUP9800467A3 (en) 1999-01-28
EP0813417A1 (en) 1997-12-29
DK0813417T3 (da) 2003-11-03
JPH10513476A (ja) 1998-12-22
EP0813417B1 (en) 2003-08-20
DE69629553D1 (de) 2003-09-25
NO315842B1 (no) 2003-11-03
CN1181016A (zh) 1998-05-06
AU4617996A (en) 1996-09-04

Similar Documents

Publication Publication Date Title
BR9607601A (pt) Uso de ácido hialurÈnico para o tratamento de cistite intersticial
DE69733826D1 (de) Behandlung von leukocyten durch photopheresis
DE3765146D1 (de) Vernetzte karboxylgruppen enthaltende kopolymere, verwendbar als verdickungsmittel in waessrigen systemen und deren herstellung.
DE69432428D1 (de) Stabilisierte elektrolytlösungen, verfahren und deren herstellung und redoxzellen und batterien, die diese lösungen enthalten
PT781092E (pt) Metodo de sensibilizacao de celulas tumorais utilizando adenovirus e1a
BR9910251A (pt) Estimulação hematopoiética
FR2715844B1 (fr) Emulsion contenant de l'acide ascorbique stabilisé, procédé de traitement cosmétique la mettant en Óoeuvre, ses utilisations.
ATE259644T1 (de) Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd
ES2063478T3 (es) Polisiloxanos de urea insaturados.
DE59608422D1 (de) Verfahren zur Herstellung von Poly(diorganosiloxanen), Mischungen, enthaltend diese Poly(diorganosiloxane) und deren Verwendung
GB1309724A (en) Nonthrombogenic polymers
DE3579194D1 (de) Neoalkoxy organo-titanate und organo-zirkonate nuetzlich als kuppler und polymerbehandlungsagenzien.
Izumrudov et al. Kinetics and mechanism of intermacromolecular reactions in polyelectrolyte solutions
TR200102199T2 (tr) Doğrusal poliüretan blok polimerlerinden oluşan, tıbbi kullanıma yönelik bir film ve böyle bir filmin üretimine yönelik metod.
BR0007284A (pt) Método para medir a concentração de um polìmero anionicamente carregado em uma solução aquosa, e, solução reagente
ATE230613T1 (de) Polymere platinverbindungen
KR850008195A (ko) 섬유처리제 및 그를 사용한 섬유처리방법
DE3777486D1 (de) Hydroperoxydierte poly-n-vinyllactam-teilchen, verfahren und verwendung davon.
ATE60057T1 (de) Verfahren zur herstellung von hexamethylcyclotrisilazan.
ATE41675T1 (de) Immobilisierung von katalytisch aktiven mirkoorganismen in agargelfasern.
ID25472A (id) Penggunaan dari bahan kimia pemercepat oksidasi dalam oksidasi dari tipe galaktosa yang dapat dioksidasi dari polimer yang mengandung konfigurasi alkohol
DE3673768D1 (de) Mittel zur bestimmung von peroxidase-aktivitaet, verfahren zur herstellung und seine verwendung.
ES8800283A1 (es) Un procedimiento para aumentar la duracion de "vitalidad" en polimero vivos obtenidos por polimerizacion catalizada por oxianiones.
SU1078894A1 (ru) Способ получения гемосовместимых полимерных гидрогелей
Fishman Anodic Behaviour of Stainless Steels in NH 3-H 3 PO 4-Water Solutions Containing Urea